Mark Blunden

423 citations
13 papers · 194 indexed · h-index 7
Topics
Renal Diseases and Glomerulopathies (3 papers)Renal and Vascular Pathologies (3 papers)Pediatric Urology and Nephrology Studies (2 papers)

In The Last Decade

Mark Blunden

12 papers receiving 186 citations

Peers

Mark Blunden
Comparison fields: 5 of 65
  • Nephrology 92
  • Emergency Medical Services 51
  • Surgery 46
  • Pulmonary and Respiratory Medicine 43
  • Critical Care and Intensive Care Medicine 20
Replace Kay Tyerman with:
Kay Tyerman United Kingdom
Irma L. Geenen Netherlands
Dawn R. Ebach United States
Giorgio Triolo Italy
Takao Sugai Japan
Carl Coghill United States
D Hillion France
Eleanor Murray United Kingdom
Judith Pichler Austria
Rebecca Evans United Kingdom
Mark Blunden relative to Kay Tyerman United Kingdom Kay Tyerman's profile →
Citations per field
00.5×3.3×
Kay Tyerman · 1×
Citations per year

Countries citing papers authored by Mark Blunden

Since Specialization
Citations

This map shows the geographic impact of Mark Blunden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Blunden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Blunden more than expected).

Fields of papers citing papers by Mark Blunden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Blunden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Blunden. The network helps show where Mark Blunden may publish in the future.

Co-authorship network of co-authors of Mark Blunden

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Blunden. A scholar is included among the top collaborators of Mark Blunden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Blunden. Mark Blunden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 0
2 1
3 5
4 1
5 24
6 39
7 1
8 3
9 29
10 46
11 7
12 21
13 17

About Mark Blunden

Mark Blunden is a scholar working on Nephrology, Aging and Transplantation, having authored 13 papers that have together received 194 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (3 papers), Renal and Vascular Pathologies (3 papers) and Pediatric Urology and Nephrology Studies (2 papers). The work is most often cited by research in Nephrology (92 citations), Emergency Medical Services (51 citations) and Aging (9 citations). Mark Blunden has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Neil Ashman, Stanley Fan, Deborah Zeitlin, John R. Prowle, Christopher J. Kirwan, Hamish Dobbie, Mary Vore, David Randall, Nicos Fotiadis and Magdi Yaqoob. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Immunological Methods and Nephrology Dialysis Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026